149 related articles for article (PubMed ID: 21718325)
1. PET/CT imaging in systemic lupus erythematosus.
Curiel R; Akin EA; Beaulieu G; DePalma L; Hashefi M
Ann N Y Acad Sci; 2011 Jun; 1228():71-80. PubMed ID: 21718325
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
Nowak M; Carrasquillo JA; Yarboro CH; Bacharach SL; Whatley M; Valencia X; Takada K; Brust DG; Illei GG
Arthritis Rheum; 2004 Apr; 50(4):1233-8. PubMed ID: 15077306
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT imaging in systemic lupus erythematosus related autoimmune haemolytic anaemia and lymphadenopathy.
Zhang X; Xu C; Wang X
Hell J Nucl Med; 2016; 19(1):42-5. PubMed ID: 26929939
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography imaging and rheumatoid arthritis.
Wang SC; Xie Q; Lv WF
Int J Rheum Dis; 2014 Mar; 17(3):248-55. PubMed ID: 24606324
[TBL] [Abstract][Full Text] [Related]
5. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings.
Lee SW; Park MC; Lee SK; Park YB
Lupus; 2012 Dec; 21(14):1531-7. PubMed ID: 22941565
[TBL] [Abstract][Full Text] [Related]
7. [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI].
Stoppe G; Wildhagen K; Meyer GJ; Schober O
Nuklearmedizin; 1989 Oct; 28(5):187-92. PubMed ID: 2813082
[TBL] [Abstract][Full Text] [Related]
8. Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient.
Barešić M; Sreter KB; Brčić L; Hećimović A; Janevski Z; Anić B
Lupus; 2015 Dec; 24(14):1546-51. PubMed ID: 26085598
[TBL] [Abstract][Full Text] [Related]
9. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.
Weiner SM; Otte A; Schumacher M; Klein R; Gutfleisch J; Brink I; Otto P; Nitzsche EU; Moser E; Peter HH
Ann Rheum Dis; 2000 May; 59(5):377-85. PubMed ID: 10784521
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in systemic lupus erythematosus-associated adenopathy.
Fey GL; Jolles PR; Buckley LM; Massey GV
Mol Imaging Biol; 2004; 6(1):7-11. PubMed ID: 15018823
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study.
Otte A; Weiner SM; Hoegerle S; Wolf R; Juengling FD; Peter HH; Nitzsche EU
Lupus; 1998; 7(1):57-9. PubMed ID: 9493152
[TBL] [Abstract][Full Text] [Related]
14. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
[TBL] [Abstract][Full Text] [Related]
15. Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
Wang L; Xiong C; Li M; Zeng X; Wang Q; Fang W; Zhao L
Ann Nucl Med; 2020 Jun; 34(6):407-414. PubMed ID: 32314147
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
[TBL] [Abstract][Full Text] [Related]
17. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
Däbritz J; Jasper N; Loeffler M; Weckesser M; Foell D
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):81-9. PubMed ID: 21042220
[TBL] [Abstract][Full Text] [Related]
19. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.
Saito T; Tamura M; Chiba Y; Katsuse O; Suda A; Kamada A; Ikura T; Abe K; Ogawa M; Minegishi K; Yoshimi R; Kirino Y; Ihata A; Hirayasu Y
J Neurol Sci; 2017 Aug; 379():127-130. PubMed ID: 28716225
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography and single photon emission computed tomography imaging of tertiary lymphoid structures during the development of lupus nephritis.
Dorraji ES; Oteiza A; Kuttner S; Martin-Armas M; Kanapathippillai P; Garbarino S; Kalda G; Scussolini M; Piana M; Fenton KA
Int J Immunopathol Pharmacol; 2021; 35():20587384211033683. PubMed ID: 34344200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
